During the past few years, virus-like particles gained more and more attention as a new, safe class of vaccines, suitable
for the prevention of virus induced infectious diseases (1) and for the therapeutical treatment of chronic diseases (2) and
drug addiction (3).
However, for the development of pharmaceutical products based upon virus-like particles (VLPs), the application of reliable
analytical tools is of great importance. For quality control purposes, the analytical methods need to be sufficiently sensitive
to detect and quantify even small varieties between different active pharmaceutical ingredient (API) bulk materials, and varying
formulations upon manufacture and storage. For the assessment of physical properties of viruses and VLPs, three main techniques
are established: transmission electron microscopy (TEM) (4–6); dynamic light scattering (DLS), often referred to as photon
correlation spectroscopy (PCS) or quasi-elastic light scattering (QELS) (7–9); and size-exclusion chromatography (SEC) (10–12).
The utilization of TEM can be ascribed to the high resolution enabling accurate particle analysis. Inherent drawbacks of this
technique are random sampling — instead of an overall sample analysis — and time-consuming preparation and measurement procedures.
DLS is described as a powerful, fast, nondestructive method for the determination of the average hydrodynamic radii and size
distributions of particles in their natural liquid environment. Thereby, increasing average sizes and polydispersity indices
indicate aggregation of the particles (13). However, the size resolution is rather low and the obtained size distribution
is rather inaccurate; the particles must differ in radius by about twofold to be resolved. Furthermore, the accurate quantification
of different particle fractions is not feasible (14,15). SEC represents the gold standard for the analysis of the physical
stability of proteins and also is used for the characterization of large biomolecules like VLPs. The drawbacks of SEC are
its limited resolution capacity of especially high molecular weight molecules and the fact that only the analysis of soluble
aggregates is possible (16). Consequently, for formulation development studies, there is a strong need for a more sensitive
analytical tool that allows separation, characterization, and quantification of different VLP fractions.
 Figure 1: Separation principle of asymmetrical flow FFF.
|
Field-flow fractionation (FFF) was introduced in 1966 as a new versatile technique for the separation and characterization
of high molecular weight molecules and particles (17). Since then, FFF techniques such as sedimentation FFF, thermal FFF,
electrical FFF, flow FFF, and asymmetrical flow FFF have been developed as reviewed recently by Fraunhofer and colleagues
(18) and Reschiglian and colleagues (19). Among these, asymmetrical flow FFF is described as the most versatile and used widely.
The theory and basic mechanisms of asymmetrical flow FFF are discussed in detail elsewhere (18, 20–22) and are only summarized
here in brief. In Figure 1, the principle of separation is illustrated.
A sample is injected into the hollow channel, which is at the downside ("accumulation wall") limited by an ultrafiltration
membrane with a certain molecular weight cut-off (open for solvent, but not for species to be analyzed). After a focusing
step, samples are eluted by a parabolic channel flow. At the same time, a cross-flow perpendicular to the carrier flow is
applied that "pushes" the dispersed particles in the direction of the accumulation wall, where the cross-flow exits the channel
via the membrane. Thereby, analytes are partitioned into regions with different flow velocities in dependence of their diffusion
properties. In essence, the larger a particle, the smaller its diffusion coefficient acting in opposite direction than the
convection from the cross-flow. Thus, the larger a particle, the stronger it is influenced by the cross-flow and the longer
it is retained in the channel. As a consequence, smaller particles elute faster than larger ones. Due to the open architecture
of the separation channel, particles in the size range of several nanometers up to a few microns are accessible for separation
by field-flow fractionation (23).
During the past decades, asymmetrical flow FFF has gained more and more attention and was applied successfully for example
for the analysis of the size and size distribution of monoclonal antibodies (16), liposomes (24), lipid–DNA complexes (25),
nanoparticles (26,27), and viruses (28). Additionally, by coupling this technique with multiangle laser light scattering (MALLS)
detection, it became possible to obtain the molecular weight distributions of the fractionated species (28–30).
In this context, it was the objective of the present work to develop an asymmetrical flow FFF method as an alternative tool
for the analysis of VLP formulations and to investigate whether asymmetrical flow FFF can provide a better insight into VLP
compositions than DLS and SEC.